Rajagopalan, Harith

RAF/RAS oncogenes and mismatch-repair status

Rajagopalan, H., Bardelli, A., Lengauer, C., Kinzler, K. W., Vogelstein, B., & Velculescu, V. E. (2002) · Nature

Genetic factors in colorectal cancerDNA Repair Mechanisms

Cited by 1,224

Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells

Yun, J., Rago, C., Cheong, I., Pagliarini, R., Angenendt, P., Rajagopalan, H., Schmidt, K., Willson, J. K. V., Markowitz, S., Zhou, S., et al. (2009) · Science

Cancer, Hypoxia, and MetabolismMetabolism, Diabetes, and Cancer

Cited by 914

Endoscopic duodenal mucosal resurfacing for the treatment of type 2 diabetes: 6-month interim analysis from the first-in-human proof-of-concept study

Rajagopalan, H., Cherrington, A. D., Thompson, C. C., Kaplan, L. M., Rubino, F., Mingrone, G., Becerra, P., Rodriguez, P., Vignolo, P., Caplan, J., et al. (2016) · Diabetes Care

Diabetes Treatment and ManagementBariatric Surgery and Outcomes

Cited by 216

Safety and efficacy of hydrothermal duodenal mucosal resurfacing in patients with type 2 diabetes: The randomised, double-blind, sham-controlled, multicentre REVITA-2 feasibility trial

Mingrone, G., van Baar, A. C., Devière, J., Hopkins, D., Moura, E., Cercato, C., Rajagopalan, H., Lopez-Talavera, J. C., White, K., Bhambhani, V., et al. (2022) · Gut

Diabetes Treatment and ManagementBariatric Surgery and Outcomes

Cited by 120

Duodenal mucosal resurfacing: proof-of-concept, procedural development, and initial implementation in the clinical setting

Haidry, R. J., van Baar, A. C., Galvao Neto, M. P., Rajagopalan, H., Caplan, J., Levin, P. S., Bergman, J. J., Rodriguez, L., Deviere, J., & Thompson, C. C. (2019) · Gastrointestinal Endoscopy

Diabetes Treatment and ManagementBariatric Surgery and Outcomes

Cited by 66